rs6673002

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016178.2(OAZ3):​c.566-278T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 152,254 control chromosomes in the GnomAD database, including 2,129 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as (no stars).

Frequency

Genomes: 𝑓 0.16 ( 2129 hom., cov: 33)

Consequence

OAZ3
NM_016178.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.382

Publications

11 publications found
Variant links:
Genes affected
OAZ3 (HGNC:8097): (ornithine decarboxylase antizyme 3) The protein encoded by this gene belongs to the ornithine decarboxylase antizyme family, which plays a role in cell growth and proliferation by regulating intracellular polyamine levels. Expression of antizymes requires +1 ribosomal frameshifting, which is enhanced by high levels of polyamines. Antizymes in turn bind to and inhibit ornithine decarboxylase (ODC), the key enzyme in polyamine biosynthesis; thus, completing the auto-regulatory circuit. This gene encodes antizyme 3, the third member of the antizyme family. Like antizymes 1 and 2, antizyme 3 inhibits ODC activity and polyamine uptake; however, it does not stimulate ODC degradation. Also, while antizymes 1 and 2 have broad tissue distribution, expression of antizyme 3 is restricted to haploid germ cells in testis, suggesting a distinct role for this antizyme in spermiogenesis. Antizyme 3 gene knockout studies showed that homozygous mutant male mice were infertile, and indicated the likely role of this antizyme in the formation of a rigid connection between the sperm head and tail during spermatogenesis. Alternatively spliced transcript variants encoding different isoforms, including one resulting from the use of non-AUG (CUG) translation initiation codon, have been found for this gene. [provided by RefSeq, Dec 2014]
TDRKH (HGNC:11713): (tudor and KH domain containing) Predicted to enable RNA binding activity. Predicted to be involved in fertilization; gamete generation; and piRNA metabolic process. Predicted to be located in mitochondrion; pi-body; and piP-body. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_016178.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016178.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OAZ3
NM_016178.2
c.566-278T>G
intron
N/ANP_057262.2Q9UMX2-1
OAZ3
NM_001301371.1
c.470-278T>G
intron
N/ANP_001288300.1H0Y7Y4
OAZ3
NM_001134939.1
c.431-278T>G
intron
N/ANP_001128411.1Q9UMX2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OAZ3
ENST00000400999.7
TSL:5
c.566-278T>G
intron
N/AENSP00000383784.3Q9UMX2-1
OAZ3
ENST00000453029.2
TSL:5
c.470-278T>G
intron
N/AENSP00000415904.2H0Y7Y4
OAZ3
ENST00000321531.10
TSL:5
c.431-278T>G
intron
N/AENSP00000313922.5A0A0G2JH29

Frequencies

GnomAD3 genomes
AF:
0.162
AC:
24598
AN:
152136
Hom.:
2122
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.218
Gnomad AMR
AF:
0.138
Gnomad ASJ
AF:
0.0916
Gnomad EAS
AF:
0.115
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.168
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.148
Gnomad OTH
AF:
0.142
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.162
AC:
24633
AN:
152254
Hom.:
2129
Cov.:
33
AF XY:
0.161
AC XY:
11955
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.211
AC:
8784
AN:
41544
American (AMR)
AF:
0.138
AC:
2104
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0916
AC:
318
AN:
3470
East Asian (EAS)
AF:
0.115
AC:
598
AN:
5186
South Asian (SAS)
AF:
0.101
AC:
486
AN:
4828
European-Finnish (FIN)
AF:
0.168
AC:
1778
AN:
10602
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.148
AC:
10049
AN:
68014
Other (OTH)
AF:
0.140
AC:
295
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1053
2107
3160
4214
5267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.153
Hom.:
312
Bravo
AF:
0.165
Asia WGS
AF:
0.129
AC:
448
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
9.7
DANN
Benign
0.89
PhyloP100
-0.38
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6673002;
hg19: chr1-151743275;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.